Overexpression of PLCG2 and TMEM38A inhibit tumor progression in clear cell renal cell carcinoma
Abstract Clear cell renal cell carcinoma is a prevalent urological malignancy, imposing substantial burdens on both patients and society. In our study, we used bioinformatics methods to select four putative target genes associated with EMT and prognosis and developed a nomogram model which could acc...
Saved in:
Main Authors: | Yiqiao Zhao, Liang Yang, Xiaojie Bai, Lu Du, Huan Lai, Yiyang Liu, Ping Chen, Michael E. DiSanto, Xinhua Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-025-86644-1 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
AURKB affects the proliferation of clear cell renal cell carcinoma by regulating fatty acid metabolism
by: Yang Yang, et al.
Published: (2025-01-01) -
APOBEC3C‐mediated NF‐κB activation enhances clear cell renal cell carcinoma progression
by: Nora Hase, et al.
Published: (2025-01-01) -
Expression pattern of cancer-associated cellular senescence genes in clear cell renal cell carcinoma distinguishes tumor subclasses with clinical implications
by: Zhongxu Zhu, et al.
Published: (2025-01-01) -
miR-9-5p/HMMR regulates the tumorigenesis and progression of clear cell renal cell carcinoma through EMT and JAK1/STAT1 signaling pathway
by: Xinyang Niu, et al.
Published: (2025-01-01) -
Methyltransferase DNMT3B promotes colorectal cancer cell proliferation by inhibiting PLCG2
by: Ji Yong, et al.
Published: (2024-08-01)